Hypotensive and heart rate-lowering effects in rats receiving milk fermented by specific Lactococcus lactis strains

Previous studies have demonstrated that milk fermented by specific Lactococcus lactis strains significantly inhibits the activity of angiotensin I-converting enzyme (ACE). However, the relationship between the ACE inhibitor and its in vivo action has revealed discrepancies. Therefore, the aim of the present study was to investigate the antihypertensive and heart rate (HR)-lowering effect of milk fermented by specific L. lactis in a murine model. Spontaneously hypertensive male rats (271 (SD14) g) were randomised into four treatment groups that were orally administered with milk fermented by L. lactis NRRL B-50 571 or L. lactis NRRL B-50 572 at 35 or 50 mg protein/kg body weight (BW), respectively. Further, two more groups were fed with different solutions as controls: a saline solution as the negative control and Captopril™ (40 mg/kg BW), a proven ACE inhibitor, as the positive control. Blood pressure and HR were monitored by the tail-cuff method before the treatments and at 2, 4, 6 and 24 h post-oral administration. The results demonstrated that milk fermented by L. lactis NRRL B-50 571 as well as by L. lactis NRRL B-50 572 presented an important systolic and diastolic blood pressure- and HR-lowering effect. Thus, milk fermented by specific L. lactis strains may present potential benefits in the prevention and treatment of CVD associated with hypertension in humans.

[1]  Toshitaka Odamaki,et al.  A one step genotypic identification of Lactococcus lactis subspecies at the species/strain levels. , 2011, Systematic and applied microbiology.

[2]  A. Anadón,et al.  Acute and repeated dose (4 weeks) oral toxicity studies of two antihypertensive peptides, RYLGY and AYFYPEL, that correspond to fragments (90-94) and (143-149) from alpha(s1)-casein. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  T. Kurtz,et al.  Recent Advances in Genetics of the Spontaneously Hypertensive Rat , 2010, Current hypertension reports.

[4]  E. Ayad.  Starter culture development for improving safety and quality of Domiati cheese. , 2009, Food microbiology.

[5]  P. Palatini.  Elevated heart rate in cardiovascular diseases: a target for treatment? , 2009, Progress in cardiovascular diseases.

[6]  J. Saavedra.  Opportunities and limitations of genetic analysis of hypertensive rat strains. , 2009, Journal of hypertension.

[7]  H. Korhonen.  Milk-derived bioactive peptides: From science to applications , 2009 .

[8]  Fang Hong,et al.  The antihypertensive effect of peptides: A novel alternative to drugs? , 2008, Peptides.

[9]  J. Hugenholtz.  The lactic acid bacterium as a cell factory for food ingredient production , 2008 .

[10]  Guan-Wen Chen,et al.  Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation , 2007 .

[11]  J. Camp,et al.  Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity , 2006 .

[12]  Yasunori Nakamura,et al.  Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension , 2005, Journal of the American College of Nutrition.

[13]  A. Aleixandre,et al.  Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca. , 2004, European journal of pharmacology.

[14]  H. Struijker‐Boudier,et al.  Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.

[15]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[16]  R. Korpela,et al.  Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. , 2001, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[17]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[18]  T. Takano,et al.  Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. , 1996, The Journal of nutrition.

[19]  N. Yamamoto,et al.  Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. , 1995, Journal of dairy science.

[20]  Y. Yamori,et al.  Effect of dietary magnesium supplementation on intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats. , 1994, Clinical and experimental hypertension.

[21]  K. Okamoto,et al.  Development of a strain of spontaneously hypertensive rats. , 1963, Japanese circulation journal.

[22]  L. Skeggs,et al.  THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME , 1956, The Journal of experimental medicine.

[23]  G. Nevárez-Moorillón,et al.  Evaluation of aroma generation of Lactococcus lactis with an electronic nose and sensory analysis. , 2008, Journal of dairy science.

[24]  S. Franklin.  The importance of diastolic blood pressure in predicting cardiovascular risk. , 2007, Journal of the American Society of Hypertension : JASH.

[25]  B. Muguerza,et al.  Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis , 2007 .

[26]  B. Muguerza,et al.  Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk , 2006 .